selected scholarly activity
-
academic article
- Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplantation. 2021
- Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported Outcomes. Clinical Lymphoma, Myeloma and Leukemia. 21:e714-e721. 2021
- Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study. Haematologica. 106:1991-1994. 2021
- External validation of the FIRST trial’s simplified frailty score in a population-based cohort. Leukemia. 35:1823-1827. 2021
- Disparities in treatment patterns and outcomes among younger and older adults with newly diagnosed multiple myeloma: A population-based study. Journal of Geriatric Oncology. 12:508-514. 2021
- Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”. Annals of Hematology. 100:1261-1266. 2021
- Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper. Journal of Geriatric Oncology. 12:499-507. 2021
- Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 21:e152-e159. 2021
- Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment. Journal of Geriatric Oncology. 11:1279-1284. 2020
- Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis. European Journal of Haematology. 105:626-634. 2020
- Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective. Journal of Geriatric Oncology. 11:1175-1181. 2020
- Registry Data and Conditioning Therapy for Allogeneic Hematopoietic Cell Transplant and Lymphoma. JAMA Oncology. 6:989-989. 2020
- Simplified frailty assessment tools: are we really capturing frailty or something else?. Leukemia. 34:1967-1969. 2020
- Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma. Journal of Geriatric Oncology. 11:764-768. 2020
- Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States. Journal of Geriatric Oncology. 11:753-760. 2020
- Geriatric hematology research at the 2019 American Society of Hematology annual meeting: Young International Society of geriatric oncology perspective paper. Journal of Geriatric Oncology. 11:735-739. 2020
- Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper. Journal of Geriatric Oncology. 11:203-211. 2020
- Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 20:98-104.e1. 2020
- The Evolving Field of Bone Imaging in Multiple Myeloma: Is it Time to Abandon Skeletal Surveys?. Current Oncology. 27:10-11. 2020
- Autologous stem cell transplant in older patients (age ≥ 65) with newly diagnosed multiple myeloma: A systematic review and meta-analysis. Journal of Geriatric Oncology. 11:93-99. 2020
- Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis. Clinical Lymphoma, Myeloma and Leukemia. 19:488-496.e6. 2019
- COMPARISON OF FRAILTY SCORES IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA: A REVIEW. The Journal of frailty & aging The Journal of frailty & aging. 8:1-7. 2019
- Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma. JCO Clinical Cancer Informatics. 2:1-13. 2018
- Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?. Drugs and Aging. 35:289-302. 2018
- Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma. Blood. 130:1679-1682. 2017
- The relationship of CD34+ dosage and platelet recovery following high dose chemotherapy and autologous CD34+ reinfusion in multiple myeloma. Transfusion and Apheresis Science. 56:552-557. 2017
- EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis. PLoS ONE. 11:e0149830-e0149830. 2016
- Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada. Hemoglobin. 39:310-315. 2015
- Venous thrombosis in inflammatory bowel disease. CMAJ. 187:55-55. 2015
- Crystal Structure of the Passenger Domain of the Escherichia coli Autotransporter EspP. Journal of Molecular Biology. 413:985-1000. 2011
- Mixed Variant Multicentric Castleman Disease Treated With Rituximab: Case Report. Journal of Pediatric Hematology/Oncology. 32:622-622. 2010
-
conference paper
- Quality of Life Assessment in Older Patients with Newly-Diagnosed Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. e232-e233. 2019
- The laboratory profile that predicts favorable outcome after Eculizumab therapy in patients with clinical features compatible with atypical hemolytic uremic syndrome. Journal of Thrombosis and Haemostasis. 712-712. 2015